Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat

Drug Metabolism and Disposition

Volumn 36, Issue 12, 2008, Pages 2452-2459

  Hein, David W ^a   Bendaly, Jean ^a   Neale, Jason R ^a   Doll, Mark A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; 4 BIPHENYLAMINE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACKCROSSING; BLADDER; BREAST; CARCINOGENICITY; COLON; CONGENIC STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS; FEMALE; FISCHER 344 RAT; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; KIDNEY; LEUKOCYTE; LIVER; LUNG; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROSTATE; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN; SMALL INTESTINE; STOMACH; XENOBIOTIC METABOLISM;

4-AMINOBENZOIC ACID; AMINOBIPHENYL COMPOUNDS; ANIMALS; ANIMALS, CONGENIC; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HETEROZYGOTE; HOMOZYGOTE; ISOENZYMES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RATS, INBRED F344; RATS, INBRED WKY; SEX CHARACTERISTICS; SULFAMETHAZINE;

RATTUS;

EID: 57349197905     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023960     Document Type: Article

References (49)

1. Ambrosone CB, Abrams SM, Gorlewska-Roberts K, and Kadlubar FF (2007) Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys 464:169-175.
2. Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, and Chang-Claude J (2008) Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 17:15-26.
3. Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, States JC, and Hein DW (2006) Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1. Pharmacogenet Genomics 16:515-525.
4. Barker DF, Walraven JM, Ristagno EH, Doll MA, States JC, and Hein DW (2008) Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat. Drug Metab Dispos 36:2435-2441.
5. Blum M, Grant DM, Demierre A, and Meyer UA (1989) Nucleotide sequence of a full-length cDNA for arylamine N-acetyltransferase from rabbit liver. Nucleic Acids Res 17:3589.
6. Boukouvala S and Fakis G (2005) Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev 37:511-564.
7. Chiang TA, Pei-Fen W, Ying LS, Wang LF, and Ko YC (1999) Mutagenicity and aromatic amine content of fumes from heated cooking oils produced in Taiwan. Food Chem Toxicol 37:125-134.
8. Chung JG, Levy GN, and Weber WW (1993) Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Drug Metab Dispos 21:1057-1063.
9. Doll MA and Hein DW (1995) Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5:247-251.
10. Faraglia B, Chen SY, Gammon MD, Zhang Y, Teitelbaum SL, Neugut AI, Ahsan H, Garbowski GC, Hibshoosh H, Lin D, et al. (2003) Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis 24:719-725.
11. Feng Y, Fretland AJ, Rustan TD, Jiang W, Becker WK, and Hein DW (1997) Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2′-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol 147:56-62.
12. Ferguson RJ, Doll MA, Baumstark BR, and Hein DW (1994) Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. Gene 140:247-249.
13. Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, and Kadlubar FF (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen 39:184-192.
14. Grundmann M, Earl CD, Sautter J, Henze C, Oertel WH, and Bandmann O (2004) Slow N-acetyltransferase 2 status leads to enhanced intrastriatal dopamine depletion in 6-hydroxydopamine-lesioned rats. Exp Neurol 187:199-202.
15. Hearse DJ and Weber WW (1973) Multiple N-acetyltransferases and drug metabolism: tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J 132:519-526.
16. Hein DW (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506-507:65-77.
17. Hein DW (2006) N-Acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25:1649-1658.
18. Hein DW, Doll MA, Nerland DE, and Fretland AJ (2006) Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster. Mol Carcinog 45:230-238.
19. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, and Grant DM (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14:1633-1638.
20. Hein DW, Doll MA, Rustan TD, Gray K, Ferguson RJ, and Feng Y (1994) Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens. Toxicol Appl Pharmacol 124:16-24.
21. Hein DW, Rustan TD, Bucher KD, Furman EJ, and Martin WJ (1991a) Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 258:232-236.
22. Hein DW, Rustan TD, Bucher KD, Martin WJ, and Furman EJ (1991b) Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Dispos 19:933-937.
23. Hein DW, Rustan TD, Bucher KD, and Miller LS (1991c) Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. J Pharmacol Exp Ther 259:699-704.
24. Hein DW, Rustan TD, Martin WJ, Bucher KD, Miller LS, and Furman EJ (1992) Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. Arch Toxicol 66:112-117.
25. Husain A, Zhang X, Doll MA, States JC, Barker DF, and Hein DW (2007a) Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements. Drug Metab Dispos 35:1649-1656.
26. Husain A, Zhang X, Doll MA, States JC, Barker DF, and Hein DW (2007b) Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab Dispos 35:721-727.
27. Jiang W, Feng Y, and Hein DW (1999) Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2′-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol 156:187-194.
28. Juberg DR, Bond JT, and Weber WW (1991) N-Acetylation of aromatic amines: genetic polymorphism in inbred rat strains. Pharmacogenetics 1:50-57.
29. Leff MA, Epstein PN, Doll MA, Fretland AJ, Devanaboyina US, Rustan TD, and Hein DW (1999) Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse. J Pharmacol Exp Ther 290:182-187.
30. Loehle JA, Cornish V, Wakefield L, Doll MA, Neale JR, Zang Y, Sim E, and Hein DW (2006) N-Acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice. J Pharmacol Exp Ther 319:724-728.
31. Lower GM Jr and Bryan GT (1973) Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochem Pharmacol 22: 1581-1588.
32. Martell KJ, Vatsis KP, and Weber WW (1991) Molecular genetic basis of rapid and slow acetylation in mice. Mol Pharmacol 40:218-227.
33. Martell KJ and Weber WW (1993) N-Acetylation polymorphism in liver and pancreas of inbred rats. Drug Metab Dispos 21:965-966.
34. Nagata K, Ozawa S, Miyata M, Shimada M, Yamazoe Y, and Kato R (1994) Primary structure and molecular basis of polymorphic appearance of an acetyltransferase (AT-II)* in hamsters. Pharmacogenetics 4:91-100.
35. Purewal M, Fretland AJ, Schut HA, Hein DW, and Wargovich MJ (2000a) Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats. Cancer Lett 149:53-60.
36. Purewal M, Velasco M, Fretland AJ, Hein DW, and Wargovich MJ (2000b) 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats. Cancer Epidemiol Biomarkers Prev 9:529-532.
37. Stabbert R, Schäfer KH, Biefel C, and Rustemeier K (2003) Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom 17:2125-2132.
38. Stanley LA, Mills IG, and Sim E (1997) Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. Pharmacogenetics 7:121-130.
39. Sugamori KS, Brenneman D, and Grant DM (2006) In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice. Drug Metab Dispos 34:1697-1702.
40. Sugamori KS, Brenneman D, Wong S, Gaedigk A, Yu V, Abramovici H, Rozmahel R, and Grant DM (2007) Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse. Drug Metab Dispos 35:1064-1070.
41. Sugamori KS, Wong S, Gaedigk A, Yu V, Abramovici H, Rozmahel R, and Grant DM (2003) Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol Pharmacol 64:170-179.
42. Tanaka T, Barnes WS, Williams GM, and Weisburger JH (1985) Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f] quinoline in rats. Jpn J Cancer Res 76:570-576.
43. van der Hel OL, Peeters PH, Hein DW, Doll MA, Grobbee DE, Kromhout D, and Bueno de Mesquita HB (2003) NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 13:399-407.
44. Wakefield L, Cornish V, Long H, Kawamura A, Zhang X, Hein DW, and Sim E (2008) Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system. Biomarkers 13:106-118.
45. Walraven JM, Barker DF, Doll MA, and Hein DW (2007) Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and functional characterization of a novel rNat3*2 genetic variant. Toxicol Sci 99:413-421.
46. Walraven JM, Doll MA, and Hein DW (2006) Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2. J Pharmacol Exp Ther 319:369-375.
47. Ware JA, Divakaruni P, and Svensson CK (1995) Comparison of acetyl coenzyme A:arylamine N-acetyltransferase activity in the liver, kidney, and intestine of male and female rats from three strains. Drug Metab Dispos 23:295-297.
48. Ware JA and Svensson CK (1996) Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat: evidence for multiplicity of N-acetyltransferases in the intestine. Biochem Pharmacol 52:1613-1620.
49. Zhang X, Lambert JC, Doll MA, Walraven JM, Arteel GE, and Hein DW (2006) 4,4′-Methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat. J Pharmacol Exp Ther 316:289-294.